PMX CommercializationPart of the separation of Vantive from Baxter must involve the establishment of their own marketing, regulatory, clinical and reimbursement departments. It can only be be these (currently nascent) departments that will "undertake a broad marketing campaign on day one of FDA approval for PMX"
Baxter Partnership Activities
In anticipation of a positive Tigris trial outcome, the Company has been working closely with Baxter on post-approval marketing plans for PMX commercialization. This includes developing product branding, pricing and roll-out plans with numerous Baxter departments, including marketing, regulatory, clinical and reimbursement. Baxter has communicated its intention to undertake a broad marketing campaign on day one of FDA approval for PMX.